Clinical Trials Browser

Phase 1/2 × UNKNOWN × Colonic Neoplasms × Clear all

NCT03545711 2018-08-06

Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer

Phase 1/2 Unknown

Gastrointestinal

Colonic Neoplasms